Committed to promoting pharmaceutical development with our expertise
Gene therapy is a promising new technique for treating cancer and genetic disorders that introducing foreign genomic materials into host cells to elicit a therapeutic benefit. The key to success of gene therapy is to create safe and efficient gene delivery vehicles. Besides non-viral vehicles, viral vectors are the most commonly used carriers for delivering DNA because of their high efficiency and safety. Creative Biolabs provides both viral and no-viral vehicles design and construction for basic research and preclinical applications. In addition, we also provide services using gene editing tools to fuel the basic research of gene therapy as well as cell therapy.
For gene therapy products, it is necessary to collect sufficient product characterization data for the clinical development including the preclinical in vitro assays of transgene expression and in vivo validation based on the syngeneic or xenograft tumor models. As a world-renowned service provider for gene therapy, Creative Biolabs offers not only a variety of services of gene therapy vehicles and strategy design, but also potency tests, safety and toxicology analysis for the gene therapy products to our clients all over the world.
Gene therapies are rapidly developed for both the research and clinical applications of the new genetic therapy techniques, which have become a critical component of the therapeutic armamentarium for a wide spectrum of human diseases. Moreover, further maturation of gene therapy approaches, safety modifications, and improvements in gene transfer efficiency and delivery systems have finally contributed to substantial clinical progress. Creative Biolabs is a leading life science service provider who has developed various robust platforms related to gene therapy covering a variety of inherited and acquired human diseases.